ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Eisai and JD.com to launch online dementia treatment in China

Japanese pharma aims to develop new drugs based on big medical data

The joint venture between Eisai and JD.com aims to have a pool of about 2,000 dementia specialists communicating with users online. (Source photos by Rei Ishii and Reuters)  
Nikkei staff writers | Japan

TOKYO -- Japanese pharmaceutical company Eisai will set up a joint venture with Chinese e-commerce group JD.com to launch an online medical services business focusing on dementia in China early next year, Nikkei has learned.

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close